Compare XBIT & ASRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XBIT | ASRV |
|---|---|---|
| Founded | 2005 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.8M | 66.2M |
| IPO Year | 2015 | 1994 |
| Metric | XBIT | ASRV |
|---|---|---|
| Price | $2.26 | $3.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 35.6K | 10.7K |
| Earning Date | 05-08-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.16% |
| EPS Growth | N/A | ★ 61.90 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $14,634,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $35.49 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.09 | $2.64 |
| 52 Week High | $3.61 | $4.04 |
| Indicator | XBIT | ASRV |
|---|---|---|
| Relative Strength Index (RSI) | 39.23 | 54.00 |
| Support Level | $2.27 | $3.62 |
| Resistance Level | $2.42 | $3.94 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 10.80 | 55.00 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.